ICER Pushes ALS Drug Makers To Moderate Launch Price While Awaiting Confirmatory Data

 
• By Jessica Merrill
value versus price
ICER issued a final assessment on ALS drugs • Source: Shutterstock

More from Drug Pricing

More from Scrip